Bank Of New York Mellon Corp Iovance Biotherapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$529 Trillion
Q2 2025

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$5.53 - $8.22 $3.25 Million - $4.83 Million	588,005 New	588,005 $3.59 Billion
Q4 2022 Feb 14, 2023	BUY	$5.62 - $10.0 $3.37 Million - $6 Million	599,853 New	599,853 $3.83 Million
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $1.48 Million - $2.04 Million	-155,446 Reduced 17.93%	711,310 $6.81 Million
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $5.78 Million - $16.6 Million	-905,251 Reduced 51.09%	866,756 $9.57 Million
Q1 2022 May 11, 2022	BUY	$12.38 - $19.1 $1.3 Million - $2 Million	104,913 Added 6.29%	1,772,007 $29.5 Million
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $857,935 - $1.43 Million	-51,839 Reduced 3.02%	1,667,094 $31.8 Million
Q3 2021 Nov 12, 2021	SELL	$20.35 - $26.63 $424,134 - $555,022	-20,842 Reduced 1.2%	1,718,933 $42.4 Million
Q2 2021 Aug 11, 2021	BUY	$16.33 - $33.07 $3.78 Million - $7.65 Million	231,203 Added 15.33%	1,739,775 $45.3 Million
Q1 2021 May 13, 2021	BUY	$28.67 - $52.59 $589,770 - $1.08 Million	20,571 Added 1.38%	1,508,572 $47.8 Million
Q4 2020 Feb 09, 2021	BUY	$28.04 - $50.26 $11.7 Million - $21 Million	417,070 Added 38.94%	1,488,001 $69 Million
Q3 2020 Nov 12, 2020	BUY	$27.75 - $36.3 $565,767 - $740,084	20,388 Added 1.94%	1,070,931 $35.3 Million
Q2 2020 Aug 12, 2020	BUY	$27.21 - $41.0 $4.53 Million - $6.83 Million	166,468 Added 18.83%	1,050,543 $28.8 Million
Q1 2020 May 06, 2020	BUY	$19.54 - $38.85 $6.14 Million - $12.2 Million	314,369 Added 55.18%	884,075 $26.5 Million
Q4 2019 Feb 14, 2020	BUY	$17.95 - $29.41 $685,833 - $1.12 Million	38,208 Added 7.19%	569,706 $15.8 Million
Q3 2019 Nov 07, 2019	SELL	$17.99 - $26.0 $497,837 - $719,498	-27,673 Reduced 4.95%	531,498 $9.67 Million
Q2 2019 Aug 12, 2019	BUY	$9.78 - $24.52 $828,199 - $2.08 Million	84,683 Added 17.85%	559,171 $13.7 Million
Q1 2019 May 14, 2019	SELL	$8.41 - $11.26 $25,877 - $34,647	-3,077 Reduced 0.64%	474,488 $4.51 Million
Q4 2018 Feb 11, 2019	BUY	$7.51 - $11.93 $921,709 - $1.46 Million	122,731 Added 34.59%	477,565 $4.23 Million
Q3 2018 Nov 09, 2018	SELL	$11.25 - $17.7 $8,820 - $13,876	-784 Reduced 0.22%	354,834 $0
Q2 2018 Aug 06, 2018	SELL	$12.45 - $16.95 $903,757 - $1.23 Million	-72,591 Reduced 16.95%	355,618 $4.55 Million
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $865,557 - $2.08 Million	106,859 Added 33.25%	428,209 $7.24 Million
Q4 2017 Feb 09, 2018	BUY	$6.65 - $9.25 $2.14 Million - $2.97 Million	321,350	321,350 $2.57 Million

Others Institutions Holding IOVA

# of Institutions

293

Shares Held

233M

Call Options Held

1.18M

Put Options Held

1.17M

Mhr Fund Management LLC New York, NY

29M
Shares

$64.6 Million
8.78% of portfolio
Vanguard Group Inc Valley Forge, PA

25.1M
Shares

$55.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

21.2M
Shares

$47.3 Million
0.0% of portfolio
Long Focus Capital Management, LLC San Juan, PR

11.8M
Shares

$26.4 Million
0.94% of portfolio
State Street Corp Boston, MA

9.89M
Shares

$22.1 Million
0.0% of portfolio

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $352M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account